{"id":"W2762733456","doi":"10.1093/annonc/mdx371.054","title":"Phase II study of individualized sunitinib (SUN) as first-line therapy for metastatic renal cell cancer: Pharmacokinetic data","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ozmosis Research (Canada); Queen Elizabeth II Health Sciences Centre; University of Alberta; Regional Municipality of Durham; London Health Sciences Centre; BC Cancer Agency; Hôpital Notre-Dame; CancerCare Manitoba; Ottawa Hospital; Princess Margaret Cancer Centre; Western University; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Toxicity; Pharmacokinetics; Sunitinib; Urology; Internal medicine; Nuclear medicine; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001265774,0.00146512,0.003333819,0.0005897338,0.0006480838,0.001371041,0.0009015413,0.001245034,0.00366413],"category_scores_gemma":[0.001005214,0.0006957518,0.001641353,0.0005784988,0.0009686904,0.001155257,0.0003232959,0.003738532,0.0007762571],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001509556,"about_ca_system_score_gemma":0.002560719,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001749467,"about_ca_topic_score_gemma":0.003922898,"domain_scores_codex":[0.9995235,0.0002029533,0.00001989524,0.00009704912,0.00005162258,0.0001049579],"domain_scores_gemma":[0.9992378,0.0001030004,0.0001474913,0.00007928326,0.00004519044,0.0003873142],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6939823,0.07518099,0.008872122,0.0009134215,0.003004171,0.0003934043,0.0004529728,0.01097979,0.05515447,0.0005683554,0.006269413,0.1442287],"study_design_scores_gemma":[0.4296324,0.5235125,0.02255232,0.00004397616,0.001268201,0.0007652724,0.0001329363,0.004843266,0.01103853,0.0005337693,0.005579942,0.00009699871],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992346,0.002201516,0.0009081084,0.0003749441,0.0001040882,0.001381623,0.001031498,0.0001596836,0.001492405],"genre_scores_gemma":[0.9917155,0.001496484,0.001708569,0.0003953884,0.0001003143,0.0009702447,0.001506947,0.0000667174,0.002039846],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00366413,"threshold_uncertainty_score":0.01225775,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3869043426930212,"score_gpt":0.5269391595123061,"score_spread":0.1400348168192849,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}